Navigation Links
Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
Date:9/25/2007

tient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medicine through training and education. Headquartered in Northern California, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products that are recognized internationally for their safety and effectiveness in treating patients with vascular disease.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
9. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
10. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
11. Malvern initiates European user group meetings for chemical imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Asterias Biotherapeutics, Inc. (OTCBB: ... of regenerative medicine, announced today the appointments of Andrew ... newly expanded Board of Directors. With these additions, the ... of whom are independent. Andy Arno ... emerging growth companies. He is currently Managing Director of ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... 20, 2014  The National Association of Drug ... achieved by the real-time, pseudoephedrine (PSE) blocking system ... Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales ... offenders and make arrests. Data released by NPLEx ... blocked the sale of more than 19,030 ...
Breaking Medicine Technology:Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 AttorneyOne.com, ... regarding all the latest information from the FDA on ... , The US FDA announced on August 19, that ... Systems, model number DPB-125MICRO145 (Part number 7-10003), by Cardiovascular ... defective saline sheaths that could fracture during use and ...
(Date:8/22/2014)... Reacting to naysayers who are being skeptical about ... top PRP therapy LA specialist has firmly stated that ... with practical well researched science and nothing to do ... new medical breakthrough technology which focuses on healing and ... therapy. , The Managing Director of one of the ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Teen substance abuse ... Toledo, OH. The rising numbers of young adults falling victim ... staggering. To help make a difference in the community, the ... valuable resource for teens seeking to overcome their chemical dependency. ... find the best youth rehab center to focus on achieving ...
(Date:8/22/2014)... 2014 The rising numbers of teenage ... Over the years, countless lives have been lost due to ... in the community a new helpline was established to provide ... Northeast Ohio who are seeking to overcome their chemical dependency ... at (300) 400-2616, parents and their teens can speak immediately ...
(Date:8/22/2014)... Lexington, North Carolina (PRWEB) August 22, 2014 ... United Church Homes and Services (UCHS ), recently ... frail and at risk seniors with limited resources in ... open floor plan, fully operational kitchen, individually controlled heating ... The HUD Section 202 supportive housing community, consists of ...
Breaking Medicine News(10 mins):Health News:Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:MetroMD With The Help Of PRP Therapy Helps People Fight Hip Injuries 2Health News:New Helpline Provides Hope for Troubled Teens in Toledo 2Health News:Troubled Teens in Akron, OH Can Receive Assistance from New Helpline for Addiction Recovery 2Health News:United Church Homes and Services Announce New Affordable Housing Community for Seniors 2
... Vall d,Hebron Hospital have diagnosed two patients affected with ... breathing due to irritating agents that are breathed in ... described two cases of patients with occupational vocal dysfunction. ... a closure in the vocal cords when inhaling. Under ...
... MINNEAPOLIS, Sept. 6 Two new issue briefs ... management,programs are evolving into employer partners to create ... ) "Corporate America Embraces New Culture ... of this emerging phenomenon:,a proactive vision for corporations ...
... NOT Vote for Merger; Says ,Shareholders Have Already ... at $5.60 per Share, NEW YORK, Sept. 6 Elliott ... (Nasdaq: BIVN ), today said the following letter has been ... Board of Directors Bioenvision, Inc. 345 Park Avenue, 41st ...
... Kris Carr is a photographer, director, producer and subject of ... Cancer." Carr is also the author of "Crazy Sexy Cancer Tips." ... and incurable cancer, but weeks later she ... treatment as her only option, Carr became determined to find ...
... Starting Drug Use with Painkillers Than Marijuana; Prescription ... Drug Abuse Remains a Concern, WASHINGTON, ... a five year low, according to the largest and,most comprehensive study of ... youth, nonmedical use of painkillers continues to be,an area of concern, with ...
... Sept. 6, 2007 CIGNA Group,Insurance today announced ... medical officer. Woolf will have responsibility for managing ... promote health and,wellness, absence management and productivity. ... clinical and business leaders,for CIGNA Group Insurance,s disability, ...
Cached Medicine News:Health News:Vocal cord dysfunction may be caused by work 2Health News:HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming 2Health News:HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming 3Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 2Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 3Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 4Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 5Health News:Author Kris Carr to Sign 'Crazy Sexy Cancer Tips' at Two Borders(R) Stores in California 2Health News:Youth Drug Use at a Five Year Low, New Survey Shows 2Health News:Youth Drug Use at a Five Year Low, New Survey Shows 3Health News:Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance 2
Standard Deflectable Catheters...
The Explorer ST "soft tip" catheter has a proximal shaft with a soft tip. It is available in both a 5F and 6F shaft configuration....
... offers a wide range of deflectable curve ... needs of children and other patients with ... demanding specifications using only the finest materials. ... wire braiding and extrusion technologies results in ...
A-Focus I & II Catheters. A-Focus steerable atrial mapping catheter. Available in 10, 12, 14 and 20 electrode configurations. (Shown with 14 electrodes)....
Medicine Products: